Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions

This publication has 28 references indexed in Scilit:

• Quantitative assessment with intracoronary ultrasound of the mechanisms of restenosis after percutaneous transluminal coronary angioplasty and directional coronary atherectomy
  The American Journal of Cardiology, 1995
• 901–40 Gender-related Differences in Smooth Muscle Cell Proliferation in Response to Estradiol and Dihydrotestosterone
  Journal of the American College of Cardiology, 1995
• Short-term administration of estrogen and vascular responce of atherosclerotic coronary arteries
  Journal of the American College of Cardiology, 1992
• Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women
  The American Journal of Cardiology, 1992
• Restenosis after coronary angioplasty: A multilvariate statistical model to relate lesion and procedure variables to restenosis
  Journal of the American College of Cardiology, 1991
• Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
  Preventive Medicine, 1991
• Patient-related variables and restenosis after percutaneous transluminal coronary angioplasty — A report from the M-HEART Groupt
  The American Journal of Cardiology, 1990
• Identifying patients at high risk for restenosis after percutaneous transluminal coronary angioplasty for unstable angina pectoris
  The American Journal of Cardiology, 1989
• Importance of stenosis morphology in the estimation of restenosis risk after elective percutaneous transluminal coronary angioplasty
  The American Journal of Cardiology, 1989
• Coronary angioplasty for unstable angina: Immediate and late results in 200 consecutive patients with identification of risk factors for unfavorable early and late outcome
  Journal of the American College of Cardiology, 1988